FOLFOX-HAIC Plus Lenvatinib and Tislelizumab in Advanced Hepatocellular Carcinoma with Arteriovenous Fistulae: A Real-World Study
Journal of Hepatocellular Carcinoma · 2026-09 · Volume 13 · 1-17
DOI: 10.2147/jhc.s621670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-09. Verfasst von Pengen Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China.
- Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China.
Zitieren
APA
Li, P., Fu, S., Wang, X., Chen, Y., Wu, J., Jiang, W., & Mao, Y. (2026). FOLFOX-HAIC Plus Lenvatinib and Tislelizumab in Advanced Hepatocellular Carcinoma with Arteriovenous Fistulae: A Real-World Study. Journal of Hepatocellular Carcinoma, Volume 13, 1-17. https://doi.org/10.2147/jhc.s621670
Vancouver
Li P, Fu S, Wang X, Chen Y, Wu J, Jiang W, et al. FOLFOX-HAIC Plus Lenvatinib and Tislelizumab in Advanced Hepatocellular Carcinoma with Arteriovenous Fistulae: A Real-World Study. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-17. doi:10.2147/jhc.s621670
BibTeX
@article{Li2026,
author = {Li, Pengen and Fu, Shumin and Wang, Xiao and Chen, Yi and Wu, Jianbing and Jiang, Weimin and Mao, Ye},
title = {FOLFOX-HAIC Plus Lenvatinib and Tislelizumab in Advanced Hepatocellular Carcinoma with Arteriovenous Fistulae: A Real-World Study},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--17},
doi = {10.2147/jhc.s621670}
}
EUVIMED